Literature DB >> 6444142

Cutaneous abscesses: natural history and management in an outpatient facility.

J L Llera1, R C Levy, J L Staneck.   

Abstract

This study investigated the natural history and treatment of cutaneous abscesses in an outpatient setting. Incision, drainage, aerobic and anaerobic cultures were done on all 78 patients entered in the study. Tenderness and fluctuance were noted in more than 80% of the patients; erythema and induration in more than 60%. Forty-one percent of all abscesses were in the anogenital region. Forty-two percent of cultured abscesses grew aerobes exclusively, 28% grew anaerobes exclusively, and 27% grew a mixture of aerobes and anaerobes. The predominant aerobic organisms were Staphylococcus and Streptococcus, which were mostly isolated from the head/neck, extremities, and axillary regions. The predominant anaerobic organisms were Peptococcus and Bacteroides, which were primarily isolated from the anogenital regions. Nearly 60% of the patients returned for reevaluation. They were equally divided between those patients taking antibiotics and those not on antibiotics. However, all patients were clinically improved.

Entities:  

Mesh:

Year:  1984        PMID: 6444142     DOI: 10.1016/0736-4679(84)90002-7

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  2 in total

1.  Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.

Authors:  David A Talan; William R Mower; Anusha Krishnadasan; Fredrick M Abrahamian; Frank Lovecchio; David J Karras; Mark T Steele; Richard E Rothman; Rebecca Hoagland; Gregory J Moran
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

2.  Subgroup Analysis of Antibiotic Treatment for Skin Abscesses.

Authors:  David A Talan; Gregory J Moran; Anusha Krishnadasan; Fredrick M Abrahamian; Frank Lovecchio; David J Karras; Mark T Steele; Richard E Rothman; William R Mower
Journal:  Ann Emerg Med       Date:  2017-10-05       Impact factor: 5.721

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.